4^th Global Summit on Advancing Oncology and Cancer Care

After the successful completion of three remarkable editions, Times Scientific Group is delighted to invite you to the 4^th Global Summit on Advancing Oncology and Cancer Care – Oncology Summit 2027, scheduled to take place on September 23–24, 2027, in Kuala Lumpur, Malaysia.  

Oncology Summit 2027 will bring together leading oncologists, cancer researchers, healthcare professionals, renowned scientists, clinicians, academicians, and industry experts from across the globe to foster scientific exchange, promote collaboration, and explore the latest developments shaping the future of oncology and cancer care. 

The conference will serve as a global platform to showcase recent advances in cancer research, precision medicine, immuno-oncology, targeted therapies, cancer diagnostics, personalized treatment, and innovative approaches to cancer care. With the continuing evolution of oncology, the summit will provide an opportunity to discuss emerging therapies, novel diagnostic technologies, clinical research, patient-centered care, and multidisciplinary approaches to improving cancer outcomes.  

Key Scientific Topics:
The scientific program will cover a broad range of topics across modern oncology, including cancer biology, tumor microenvironment, cancer genomics, molecular oncology, biomarkers, early cancer detection, liquid biopsies, precision oncology, immunotherapy, targeted therapy, and advances in cancer therapeutics.  

Special sessions will focus on breast cancer, lung cancer, colorectal cancer, prostate cancer, gynecologic cancers, hematologic malignancies, pediatric oncology, ovarian cancers, surgical oncology, radiation oncology, medical oncology, cancer prevention, survivorship, and supportive and palliative care.

The summit will also highlight emerging innovations such as CAR-T cell therapy, cancer vaccines, artificial intelligence in oncology, digital health, novel drug delivery systems, next-generation sequencing, real-world evidence, and innovative clinical trial strategies. Discussions will explore how these developments can contribute to more effective, personalized, and accessible cancer care.

The conference will provide a platform for researchers and healthcare professionals to exchange knowledge, present new findings, discuss clinical experiences, and identify opportunities for future collaboration. Particular emphasis will be placed on translating research discoveries into clinical practice and strengthening global approaches to cancer care. Oncology Summit 2027 will explore how scientific discoveries, technological innovation, and international collaboration are transforming cancer prevention, diagnosis, treatment, and survivorship.

Why Kuala Lumpur?
Kuala Lumpur, the vibrant capital of Malaysia, provides an excellent setting for an international oncology conference. As a major center for healthcare, education, business, and innovation in Southeast Asia, the city offers opportunities for professionals from different regions to connect and collaborate.
With its modern infrastructure, international connectivity, diverse cultural environment, and growing healthcare and research ecosystem, Kuala Lumpur provides an engaging environment for scientific discussions, professional networking, and international collaboration. The city's accessibility and welcoming atmosphere make it a suitable destination for delegates attending a global conference on oncology and cancer care.

Visa & Travel Assistance:
All registered international participants will receive an official invitation letter to with their visa application. We recommend submitting applications early to ensure timely processing and smooth travel. Register early for the conference to secure your spot and enjoy all sessions, networking opportunities, and conference benefits without any hassle.

Join Oncology Summit 2027
We look forward to welcoming you to Kuala Lumpur, Malaysia, on September 23–24, 2027, for an engaging and impactful scientific gathering dedicated to advancing oncology and cancer care.
Group registrations for participants are available, and special discounts are offered for group participation. Kindly contact us at [email protected] for more details and information on how to proceed.

                                                                                       Publishing Partner
                             

The Journal of Translational Genetics and Genomics (ISSN 2578-5281) is an open access international journal promoting the translation of basic research into clinical practice. The aims of the journal are to publish high quality, original, peer-reviewed research articles of discoveries in the area of genetics and genomics. Coverage extends, but not limited to, the basic and clinical studies related to human genetics including molecular and clinical genetics, biochemistry, molecular signaling, epigenetics, pharmaceutical sciences, pharmacogenomics, molecular biology, pharmacology and oncology.

The journal also emphasizes on the development of clinical potential and application of new therapeutics, disease-specific biomarkers, cellular and molecular medicine, bioinformatics, artificial intelligence, drug application, and health policy. Manuscript of interest on clinical implications for the prevention and treatment of diseases will be given preference.

The article types include original research, review, meta-analysis, systematic review, technical notes, commentary, letter to editor, opinion, perspective and editorial.